VAERS reports by lot

GSK Hepatitis A lot D94MK: VAERS reports

28 VAERS reports list lot D94MK as a GSK Hepatitis A vaccine, received between 2018-11-05 and 2023-03-28. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
28
Reports
0%
Marked serious
0
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological2238%
Injection-site / Local reaction1119%
Musculoskeletal47%
Dermatological (non-injection-site)47%
Cardiac / Cardiovascular35%
Gastrointestinal35%
Psychiatric / Neuropsychiatric35%
General / Systemic (non-local)35%
Allergic / Anaphylactic23%
Respiratory23%
Autoimmune / Immune-mediated12%

Where reports came from

U.S. state of the reporter, where given (top 11).

Kentucky7
New Hampshire4
West Virginia4
Pennsylvania3
Indiana2
Ohio2
Michigan1
Arkansas1
Tennessee1
Mississippi1
Georgia1

Reports by month received

2018-116
2018-126
2019-011
2019-022
2019-031
2019-041
2019-052
2019-061
2019-091
2019-111
2019-121
2020-031
2021-071
2021-081
2021-091
2023-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.